img

Global rhEPO Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global rhEPO Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

The process of supplying EPO externally, usually with the help of recombinant DNA technology in a cell culture, is known as rhEPO. rhEPO is used to treat anemia due to neural diseases, injuries, kidney diseases or cancer.
rhEPO report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global rhEPO market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospitals and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for rhEPO industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, rhEPO key manufacturers include 3SBio, Shanghai Chemo, Chengdu Diao, NCPC Genetech, Kyowa Hakko Kirin, Shandong Kexing, Ahua Pharmaceutical, Biosidus and Dragon Pharma, etc. 3SBio, Shanghai Chemo, Chengdu Diao are top 3 players and held % sales share in total in 2022.
rhEPO can be divided into ESRD, Cancer, HIV and Wounds and neural disease, etc. ESRD is the mainstream product in the market, accounting for % sales share globally in 2022.
rhEPO is widely used in various fields, such as Hospitals and Retail Pharmacies, etc. Hospitals provides greatest supports to the rhEPO industry development. In 2022, global % sales of rhEPO went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global rhEPO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


3SBio
Shanghai Chemo
Chengdu Diao
NCPC Genetech
Kyowa Hakko Kirin
Shandong Kexing
Ahua Pharmaceutical
Biosidus
Dragon Pharma
Segment by Type
ESRD
Cancer
HIV
Wounds and neural disease

Segment by Application


Hospitals
Retail Pharmacies

Segment by Region


North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the rhEPO market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of rhEPO, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the rhEPO industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of rhEPO in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, rhEPO introduction, etc. rhEPO Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of rhEPO market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 rhEPO Market Overview
1.1 rhEPO Product Overview
1.2 rhEPO Market Segment by Type
1.2.1 ESRD
1.2.2 Cancer
1.2.3 HIV
1.2.4 Wounds and neural disease
1.3 Global rhEPO Market Size by Type
1.3.1 Global rhEPO Market Size Overview by Type (2018-2029)
1.3.2 Global rhEPO Historic Market Size Review by Type (2018-2024)
1.3.3 Global rhEPO Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America rhEPO Sales Breakdown by Type (2018-2024)
1.4.2 Europe rhEPO Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific rhEPO Sales Breakdown by Type (2018-2024)
1.4.4 Latin America rhEPO Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa rhEPO Sales Breakdown by Type (2018-2024)
2 Global rhEPO Market Competition by Company
2.1 Global Top Players by rhEPO Sales (2018-2024)
2.2 Global Top Players by rhEPO Revenue (2018-2024)
2.3 Global Top Players by rhEPO Price (2018-2024)
2.4 Global Top Manufacturers rhEPO Manufacturing Base Distribution, Sales Area, Product Type
2.5 rhEPO Market Competitive Situation and Trends
2.5.1 rhEPO Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by rhEPO Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in rhEPO as of 2022)
2.7 Date of Key Manufacturers Enter into rhEPO Market
2.8 Key Manufacturers rhEPO Product Offered
2.9 Mergers & Acquisitions, Expansion
3 rhEPO Status and Outlook by Region
3.1 Global rhEPO Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global rhEPO Historic Market Size by Region
3.2.1 Global rhEPO Sales in Volume by Region (2018-2024)
3.2.2 Global rhEPO Sales in Value by Region (2018-2024)
3.2.3 Global rhEPO Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global rhEPO Forecasted Market Size by Region
3.3.1 Global rhEPO Sales in Volume by Region (2024-2029)
3.3.2 Global rhEPO Sales in Value by Region (2024-2029)
3.3.3 Global rhEPO Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global rhEPO by Application
4.1 rhEPO Market Segment by Application
4.1.1 Hospitals
4.1.2 Retail Pharmacies
4.2 Global rhEPO Market Size by Application
4.2.1 Global rhEPO Market Size Overview by Application (2018-2029)
4.2.2 Global rhEPO Historic Market Size Review by Application (2018-2024)
4.2.3 Global rhEPO Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America rhEPO Sales Breakdown by Application (2018-2024)
4.3.2 Europe rhEPO Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific rhEPO Sales Breakdown by Application (2018-2024)
4.3.4 Latin America rhEPO Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa rhEPO Sales Breakdown by Application (2018-2024)
5 North America rhEPO by Country
5.1 North America rhEPO Historic Market Size by Country
5.1.1 North America rhEPO Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America rhEPO Sales in Volume by Country (2018-2024)
5.1.3 North America rhEPO Sales in Value by Country (2018-2024)
5.2 North America rhEPO Forecasted Market Size by Country
5.2.1 North America rhEPO Sales in Volume by Country (2024-2029)
5.2.2 North America rhEPO Sales in Value by Country (2024-2029)
6 Europe rhEPO by Country
6.1 Europe rhEPO Historic Market Size by Country
6.1.1 Europe rhEPO Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe rhEPO Sales in Volume by Country (2018-2024)
6.1.3 Europe rhEPO Sales in Value by Country (2018-2024)
6.2 Europe rhEPO Forecasted Market Size by Country
6.2.1 Europe rhEPO Sales in Volume by Country (2024-2029)
6.2.2 Europe rhEPO Sales in Value by Country (2024-2029)
7 Asia-Pacific rhEPO by Region
7.1 Asia-Pacific rhEPO Historic Market Size by Region
7.1.1 Asia-Pacific rhEPO Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific rhEPO Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific rhEPO Sales in Value by Region (2018-2024)
7.2 Asia-Pacific rhEPO Forecasted Market Size by Region
7.2.1 Asia-Pacific rhEPO Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific rhEPO Sales in Value by Region (2024-2029)
8 Latin America rhEPO by Country
8.1 Latin America rhEPO Historic Market Size by Country
8.1.1 Latin America rhEPO Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America rhEPO Sales in Volume by Country (2018-2024)
8.1.3 Latin America rhEPO Sales in Value by Country (2018-2024)
8.2 Latin America rhEPO Forecasted Market Size by Country
8.2.1 Latin America rhEPO Sales in Volume by Country (2024-2029)
8.2.2 Latin America rhEPO Sales in Value by Country (2024-2029)
9 Middle East and Africa rhEPO by Country
9.1 Middle East and Africa rhEPO Historic Market Size by Country
9.1.1 Middle East and Africa rhEPO Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa rhEPO Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa rhEPO Sales in Value by Country (2018-2024)
9.2 Middle East and Africa rhEPO Forecasted Market Size by Country
9.2.1 Middle East and Africa rhEPO Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa rhEPO Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 3SBio
10.1.1 3SBio Company Information
10.1.2 3SBio Introduction and Business Overview
10.1.3 3SBio rhEPO Sales, Revenue and Gross Margin (2018-2024)
10.1.4 3SBio rhEPO Products Offered
10.1.5 3SBio Recent Development
10.2 Shanghai Chemo
10.2.1 Shanghai Chemo Company Information
10.2.2 Shanghai Chemo Introduction and Business Overview
10.2.3 Shanghai Chemo rhEPO Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Shanghai Chemo rhEPO Products Offered
10.2.5 Shanghai Chemo Recent Development
10.3 Chengdu Diao
10.3.1 Chengdu Diao Company Information
10.3.2 Chengdu Diao Introduction and Business Overview
10.3.3 Chengdu Diao rhEPO Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Chengdu Diao rhEPO Products Offered
10.3.5 Chengdu Diao Recent Development
10.4 NCPC Genetech
10.4.1 NCPC Genetech Company Information
10.4.2 NCPC Genetech Introduction and Business Overview
10.4.3 NCPC Genetech rhEPO Sales, Revenue and Gross Margin (2018-2024)
10.4.4 NCPC Genetech rhEPO Products Offered
10.4.5 NCPC Genetech Recent Development
10.5 Kyowa Hakko Kirin
10.5.1 Kyowa Hakko Kirin Company Information
10.5.2 Kyowa Hakko Kirin Introduction and Business Overview
10.5.3 Kyowa Hakko Kirin rhEPO Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Kyowa Hakko Kirin rhEPO Products Offered
10.5.5 Kyowa Hakko Kirin Recent Development
10.6 Shandong Kexing
10.6.1 Shandong Kexing Company Information
10.6.2 Shandong Kexing Introduction and Business Overview
10.6.3 Shandong Kexing rhEPO Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Shandong Kexing rhEPO Products Offered
10.6.5 Shandong Kexing Recent Development
10.7 Ahua Pharmaceutical
10.7.1 Ahua Pharmaceutical Company Information
10.7.2 Ahua Pharmaceutical Introduction and Business Overview
10.7.3 Ahua Pharmaceutical rhEPO Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Ahua Pharmaceutical rhEPO Products Offered
10.7.5 Ahua Pharmaceutical Recent Development
10.8 Biosidus
10.8.1 Biosidus Company Information
10.8.2 Biosidus Introduction and Business Overview
10.8.3 Biosidus rhEPO Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Biosidus rhEPO Products Offered
10.8.5 Biosidus Recent Development
10.9 Dragon Pharma
10.9.1 Dragon Pharma Company Information
10.9.2 Dragon Pharma Introduction and Business Overview
10.9.3 Dragon Pharma rhEPO Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Dragon Pharma rhEPO Products Offered
10.9.5 Dragon Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 rhEPO Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 rhEPO Industrial Chain Analysis
11.4 rhEPO Market Dynamics
11.4.1 rhEPO Industry Trends
11.4.2 rhEPO Market Drivers
11.4.3 rhEPO Market Challenges
11.4.4 rhEPO Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 rhEPO Distributors
12.3 rhEPO Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of ESRD
Table 2. Major Company of Cancer
Table 3. Major Company of HIV
Table 4. Major Company of Wounds and neural disease
Table 5. Global rhEPO Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global rhEPO Sales by Type (2018-2024) & (K MT)
Table 7. Global rhEPO Sales Market Share in Volume by Type (2018-2024)
Table 8. Global rhEPO Sales by Type (2018-2024) & (US& Million)
Table 9. Global rhEPO Market Share in Value by Type (2018-2024)
Table 10. Global rhEPO Price by Type (2018-2024) & (USD/MT)
Table 11. Global rhEPO Sales by Type (2024-2029) & (K MT)
Table 12. Global rhEPO Sales Market Share in Volume by Type (2024-2029)
Table 13. Global rhEPO Sales by Type (2024-2029) & (US$ Million)
Table 14. Global rhEPO Sales Market Share in Value by Type (2024-2029)
Table 15. Global rhEPO Price by Type (2024-2029) & (USD/MT)
Table 16. North America rhEPO Sales by Type (2018-2024) & (K MT)
Table 17. North America rhEPO Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe rhEPO Sales (K MT) by Type (2018-2024)
Table 19. Europe rhEPO Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific rhEPO Sales (K MT) by Type (2018-2024)
Table 21. Asia-Pacific rhEPO Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America rhEPO Sales (K MT) by Type (2018-2024)
Table 23. Latin America rhEPO Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa rhEPO Sales (K MT) by Type (2018-2024)
Table 25. Middle East and Africa rhEPO Sales by Type (2018-2024) & (US$ Million)
Table 26. Global rhEPO Sales by Company (2018-2024) & (K MT)
Table 27. Global rhEPO Sales Share by Company (2018-2024)
Table 28. Global rhEPO Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global rhEPO Revenue Share by Company (2018-2024)
Table 30. Global Market rhEPO Price by Company (2018-2024) & (USD/MT)
Table 31. Global rhEPO Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global rhEPO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in rhEPO as of 2022)
Table 34. Date of Key Manufacturers Enter into rhEPO Market
Table 35. Key Manufacturers rhEPO Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global rhEPO Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global rhEPO Sales by Region (2018-2024) & (K MT)
Table 39. Global rhEPO Sales Market Share in Volume by Region (2018-2024)
Table 40. Global rhEPO Sales by Region (2018-2024) & (US$ Million)
Table 41. Global rhEPO Sales Market Share in Value by Region (2018-2024)
Table 42. Global rhEPO Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 43. Global rhEPO Sales by Region (2024-2029) & (K MT)
Table 44. Global rhEPO Sales Market Share in Volume by Region (2024-2029)
Table 45. Global rhEPO Sales by Region (2024-2029) & (US$ Million)
Table 46. Global rhEPO Sales Market Share in Value by Region (2024-2029)
Table 47. Global rhEPO Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2029)
Table 48. Global rhEPO Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global rhEPO Sales by Application (2018-2024) & (K MT)
Table 50. Global rhEPO Sales Market Share in Volume by Application (2018-2024)
Table 51. Global rhEPO Sales by Application (2018-2024) & (US$ Million)
Table 52. Global rhEPO Sales Market Share in Value by Application (2018-2024)
Table 53. Global rhEPO Price by Application (2018-2024) & (USD/MT)
Table 54. Global rhEPO Sales by Application (2024-2029) & (K MT)
Table 55. Global rhEPO Sales Market Share in Volume by Application (2024-2029)
Table 56. Global rhEPO Sales by Application (2024-2029) & (US$ Million)
Table 57. Global rhEPO Sales Market Share in Value by Application (2024-2029)
Table 58. Global rhEPO Price by Application (2024-2029) & (USD/MT)
Table 59. North America rhEPO Sales by Application (2018-2024) (K MT)
Table 60. North America rhEPO Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe rhEPO Sales by Application (2018-2024) (K MT)
Table 62. Europe rhEPO Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific rhEPO Sales by Application (2018-2024) (K MT)
Table 64. Asia-Pacific rhEPO Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America rhEPO Sales by Application (2018-2024) (K MT)
Table 66. Latin America rhEPO Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa rhEPO Sales by Application (2018-2024) (K MT)
Table 68. Middle East and Africa rhEPO Sales by Application (2018-2024) & (US$ Million)
Table 69. North America rhEPO Sales by Country (2018-2024) & (K MT)
Table 70. North America rhEPO Sales Market Share in Volume by Country (2018-2024)
Table 71. North America rhEPO Sales by Country (2018-2024) & (US$ Million)
Table 72. North America rhEPO Sales Market Share in Value by Country (2018-2024)
Table 73. North America rhEPO Sales by Country (2024-2029) & (K MT)
Table 74. North America rhEPO Sales Market Share in Volume by Country (2024-2029)
Table 75. North America rhEPO Sales by Country (2024-2029) & (US$ Million)
Table 76. North America rhEPO Sales Market Share in Value by Country (2024-2029)
Table 77. Europe rhEPO Sales by Country (2018-2024) & (K MT)
Table 78. Europe rhEPO Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe rhEPO Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe rhEPO Sales Market Share in Value by Country (2018-2024)
Table 81. Europe rhEPO Sales by Country (2024-2029) & (K MT)
Table 82. Europe rhEPO Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe rhEPO Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe rhEPO Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific rhEPO Sales by Region (2018-2024) & (K MT)
Table 86. Asia-Pacific rhEPO Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific rhEPO Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific rhEPO Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific rhEPO Sales by Region (2024-2029) & (K MT)
Table 90. Asia-Pacific rhEPO Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific rhEPO Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific rhEPO Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America rhEPO Sales by Country (2018-2024) & (K MT)
Table 94. Latin America rhEPO Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America rhEPO Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America rhEPO Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America rhEPO Sales by Country (2024-2029) & (K MT)
Table 98. Latin America rhEPO Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America rhEPO Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America rhEPO Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa rhEPO Sales by Country (2018-2024) & (K MT)
Table 102. Middle East and Africa rhEPO Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa rhEPO Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa rhEPO Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa rhEPO Sales by Country (2024-2029) & (K MT)
Table 106. Middle East and Africa rhEPO Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa rhEPO Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa rhEPO Sales Market Share in Value by Country (2024-2029)
Table 109. 3SBio Company Information
Table 110. 3SBio Introduction and Business Overview
Table 111. 3SBio rhEPO Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 112. 3SBio rhEPO Product
Table 113. 3SBio Recent Development
Table 114. Shanghai Chemo Company Information
Table 115. Shanghai Chemo Introduction and Business Overview
Table 116. Shanghai Chemo rhEPO Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 117. Shanghai Chemo rhEPO Product
Table 118. Shanghai Chemo Recent Development
Table 119. Chengdu Diao Company Information
Table 120. Chengdu Diao Introduction and Business Overview
Table 121. Chengdu Diao rhEPO Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 122. Chengdu Diao rhEPO Product
Table 123. Chengdu Diao Recent Development
Table 124. NCPC Genetech Company Information
Table 125. NCPC Genetech Introduction and Business Overview
Table 126. NCPC Genetech rhEPO Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 127. NCPC Genetech rhEPO Product
Table 128. NCPC Genetech Recent Development
Table 129. Kyowa Hakko Kirin Company Information
Table 130. Kyowa Hakko Kirin Introduction and Business Overview
Table 131. Kyowa Hakko Kirin rhEPO Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 132. Kyowa Hakko Kirin rhEPO Product
Table 133. Kyowa Hakko Kirin Recent Development
Table 134. Shandong Kexing Company Information
Table 135. Shandong Kexing Introduction and Business Overview
Table 136. Shandong Kexing rhEPO Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 137. Shandong Kexing rhEPO Product
Table 138. Shandong Kexing Recent Development
Table 139. Ahua Pharmaceutical Company Information
Table 140. Ahua Pharmaceutical Introduction and Business Overview
Table 141. Ahua Pharmaceutical rhEPO Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 142. Ahua Pharmaceutical rhEPO Product
Table 143. Ahua Pharmaceutical Recent Development
Table 144. Biosidus Company Information
Table 145. Biosidus Introduction and Business Overview
Table 146. Biosidus rhEPO Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 147. Biosidus rhEPO Product
Table 148. Biosidus Recent Development
Table 149. Dragon Pharma Company Information
Table 150. Dragon Pharma Introduction and Business Overview
Table 151. Dragon Pharma rhEPO Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 152. Dragon Pharma rhEPO Product
Table 153. Dragon Pharma Recent Development
Table 154. Key Raw Materials Lists
Table 155. Raw Materials Key Suppliers Lists
Table 156. rhEPO Market Trends
Table 157. rhEPO Market Drivers
Table 158. rhEPO Market Challenges
Table 159. rhEPO Market Restraints
Table 160. rhEPO Distributors List
Table 161. rhEPO Downstream Customers
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. rhEPO Product Picture
Figure 2. Global rhEPO Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global rhEPO Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global rhEPO Sales Status and Outlook (2018-2029) & (K MT)
Figure 5. Product Picture of ESRD
Figure 6. Global ESRD Sales YoY Growth (2018-2029) & (K MT)
Figure 7. Product Picture of Cancer
Figure 8. Global Cancer Sales YoY Growth (2018-2029) & (K MT)
Figure 9. Product Picture of HIV
Figure 10. Global HIV Sales YoY Growth (2018-2029) & (K MT)
Figure 11. Product Picture of Wounds and neural disease
Figure 12. Global Wounds and neural disease Sales YoY Growth (2018-2029) & (K MT)
Figure 13. Global rhEPO Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global rhEPO Sales Market Share by Type in 2022 & 2029
Figure 15. North America rhEPO Sales Market Share in Volume by Type in 2022
Figure 16. North America rhEPO Sales Market Share in Value by Type in 2022
Figure 17. Europe rhEPO Sales Market Share in Volume by Type in 2022
Figure 18. Europe rhEPO Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific rhEPO Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific rhEPO Sales Market Share in Value by Type in 2022
Figure 21. Latin America rhEPO Sales Market Share in Volume by Type in 2022
Figure 22. Latin America rhEPO Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa rhEPO Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa rhEPO Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by rhEPO Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by rhEPO Revenue in 2022
Figure 27. rhEPO Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospitals
Figure 29. Global Hospitals Sales YoY Growth (2018-2029) & (K MT)
Figure 30. Product Picture of Retail Pharmacies
Figure 31. Global Retail Pharmacies Sales YoY Growth (2018-2029) & (K MT)
Figure 32. Global rhEPO Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global rhEPO Sales Market Share by Application in 2022 & 2029
Figure 34. North America rhEPO Sales Market Share in Volume by Application in 2022
Figure 35. North America rhEPO Sales Market Share in Value by Application in 2022
Figure 36. Europe rhEPO Sales Market Share in Volume by Application in 2022
Figure 37. Europe rhEPO Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific rhEPO Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific rhEPO Sales Market Share in Value by Application in 2022
Figure 40. Latin America rhEPO Sales Market Share in Volume by Application in 2022
Figure 41. Latin America rhEPO Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa rhEPO Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. rhEPO Manufacturing Cost Structure
Figure 45. rhEPO Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries